Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan

Cost-effectiveness analysis of COVID-19 booster vaccination with BNT162b2 in Japan

Background The aim of this study was to evaluate the public health and economic impact of the COVID-19 booster vaccination with BNT162b2 in Japan during an Omicron-dominant period from early 2022.Research design and methods A combined cohort Markov decision tree model estimated the cost-effectivenes...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitsuhiro Nagano, Kazumasa Kamei, Hiroyuki Matsuda, Chihiro Takahashi, Jingyan Yang, Koji Wada, Naohiro Yonemoto
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Expert Review of Vaccines
Subjects:
COVID-19
SARS-CoV-2
vaccine
booster
cost-effectiveness
Japan
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2024.2323133
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items